Results 51 to 60 of about 193,444 (218)
The use of vasodilators in the management of angina
Vasodilators are used as first line agents to relief symptoms of angina in clinical setting. First line vasodilating agents used in the management of angina include calcium channel blockers and nitrates.
Gemana, Tersee
core
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
Buxton, Martin J +15 more
core +1 more source
Aim. To assess compliance with international clinical guidelines on coronary heart disease (CHD) secondary prevention, as well as on stable angina pectoris diagnostics and treatment, in Russian clinical practice settings. Material and methods .
R. G. Oganov +6 more
doaj
BackgroundAngina is common both before and after myocardial infarction (MI). Whether the change in angina status within the first 30 days after MI is associated with subsequent readmission and angina persistence is unknown.
Jacob A. Doll +6 more
doaj +1 more source
Objective: To investigate the prognosis of angina among people with and without diagnosis by a doctor and an abnormal cardiovascular test result. Design: Prospective cohort study with a median follow up of 11 years.
Shipley, M. +11 more
core
Objetivo: describir las características clínicas y paraclínicas de los pacientes con coronariografía normal o sin lesiones significativas. Diseño: descriptivo, retrospectivo. Metodología: se revisaron las historias clínicas y se registraron los hallazgos
Juan Andrés Delgado Restrepo +3 more
doaj
Gingival overgrowth (GO) is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Amlodipine is a comparatively new calcium channel blocker and is being used with increasing frequency in the ...
Mohan Kumar Pasupuleti +3 more
doaj +1 more source
How to diagnose and manage angina without obstructive coronary artery disease: Lessons from the British Heart Foundation CorMicA trial [PDF]
Patients with symptoms and/or signs of ischaemia but no obstructive coronary artery disease (INOCA) present a diagnostic and therapeutic challenge.
Thomas J Ford +3 more
core +1 more source
Mechanisms of Ischemic Heart Disease Development in Type 2 Diabetes Patients Based on Renal Function
Ischemic heart disease (IHD) remains a leading cause of mortality and disability in Ukraine and globally, primarily due to stenosing atherosclerosis of the coronary arteries.
Georgii B. Mankovskyi +3 more
doaj +1 more source
M Patrick Witvliet,1,2 E Karin Arkenbout,3 Pieter W Kamphuisen1,4 1Department of Internal Medicine, Tergooi Medical Center, Hilversum, the Netherlands; 2Department of General Practice, Amsterdam UMC Location University of Amsterdam, Amsterdam, the ...
Witvliet MP, Arkenbout EK, Kamphuisen PW
doaj

